Ceralasertib (AZD6738) is a potent, selective, ATP-competitive ATR inhibitor. It affects DNA damage response and ATR-Chk1 signaling by blocking Chk1 phosphorylation and inducing replication catastrophe, effectively inhibiting tumor cell proliferation and promoting apoptosis.